Background-Pulmonary rehabilitation programmes improve the health of patien
ts disabled by lung disease but their cost effectiveness is unproved. We un
dertook a cost/utility analysis in conjunction with a randomised controlled
clinical trial of pulmonary rehabilitation versus standard care.
Methods-Two hundred patients, mainly with chronic obstructive pulmonary dis
ease, were randomly assigned to either an 18 visit, 6 week rehabilitation p
rogramme or standard medical management. The difference between the mean co
st of 12 months of care for patients in the rehabilitation and control grou
ps (incremental cost) and the difference between the two groups in quality
adjusted life years (QALYs) gained (incremental utility) were determined. T
he ratio between incremental cost and utility (incremental cost/utility rat
io) was calculated.
Results-Each rehabilitation programme for up to 20 patients cost pound 12 1
20. The mean incremental cost of adding rehabilitation to standard care was
pound -152 (95% CI -881 to 577) per patient, p=NS. The incremental utility
of adding rehabilitation was 0.030 (95% CI 0.002 to 0.058) QALYs per patie
nt, p=0.03. The point estimate of the incremental cost/utility ratio was th
erefore negative. The bootstrapping technique was used to model the distrib
ution of cost/utility estimates possible from the data. A high likelihood o
f generating QALYs at negative or relatively low cost was indicated. The pr
obability of the cost per QALY generated being below pound0 was 0.64.
Conclusions-This outpatient pulmonary rehabilitation programme produces cos
t per QALY ratios within bounds considered to be cost effective and is like
ly to result in financial benefits to the health service.